Faculty of Medicine
lterrat's bookmarks 2017-06-13
Summary:
"An innovative drug discovery organization linked to the University of Toronto has received $33 million to strengthen its disease research, which is shared openly with the world.
Canadian scientists are at the forefront of open science, making their research publicly available so that other researchers, healthcare companies, doctors and nurses can use the information to quickly develop life-saving cures for Canadians. The SGC is a pioneer in open science. Since its inception in 2004, Consortium scientists have shared all research results and output with no restrictions on use, and without filing patents. The approach protects against waste and duplication of effort, leading to faster development of new treatments.
The new funds come from the Canadian and Ontario governments, along with the not-for-profit Genome Canada, and pharmaceutical companies. The funding will help translate scientific discoveries into cures for patients with a range of diseases such as cancer, ALS, Huntington’s disease, malaria and tuberculosis."